Aerts-Janssens SRL
Aerts-Janssens reported total assets of €1.64m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of Aerts-Janssens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Aerts-Janssens's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 09 Apr 2025
- Year ended 31 Dec 2023filed on 16 May 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Aerts-Janssens's financial analysis
- Solvency87.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Aerts-Janssens
Aerts-Janssens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0882.035.747
- VAT number
- BE0882035747
- Peppol
- Registered · 0208:0882035747 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jun 2006
- Registered office
- 2900 Schoten
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Aerts-Janssens (SRL) has been based in Schoten since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,904 € and equity of €1.43m; its revenue is not published. Its solvency stands at 87.2%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Aerts-Janssens
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Gedopt Retail sale of pharmaceutical products Schoten · balance sheet €1.64m
- Pharmacie de Lillois Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.64m
- Linterpharma Retail sale of pharmaceutical products Linter · balance sheet €1.63m
- De Magistrale Retail sale of pharmaceutical products Brakel · balance sheet €1.63m
- Lindephar Retail sale of pharmaceutical products Evergem · balance sheet €1.63m
- Devaphar Retail sale of pharmaceutical products Brussels · balance sheet €1.63m
- Centrumapotheek Beerse Retail sale of pharmaceutical products Beerse · balance sheet €1.63m
- Apotheekcentra Retail sale of pharmaceutical products Koksijde · balance sheet €1.66m
Frequently asked questions about Aerts-Janssens
What is the revenue of Aerts-Janssens?
Aerts-Janssens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Aerts-Janssens?
In Belgium, the VAT number is the company number prefixed with BE: BE0882035747 for Aerts-Janssens, if the company is VAT-registered. Its company number (CBE) is 0882.035.747.
Where is the registered office of Aerts-Janssens?
According to the CBE register, the registered office of Aerts-Janssens is in 2900 Schoten.
What is the equity of Aerts-Janssens?
At the close of the 2025 financial year, the equity of Aerts-Janssens amounts to 1,432,725 €, a solvency of 87.2% of total assets.
Who manages Aerts-Janssens?
The register lists 2 active mandates at Aerts-Janssens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Aerts-Janssens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →